Sec. 3223. GAO STUDY AND REPORT ON HOSPICE SAFE DRUG MANAGEMENT

217 words·~1 min read·/statute-compilations/comps-15290/sec-3223

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 3223 GAO STUDY AND REPORT ON HOSPICE SAFE DRUG MANAGEMENT ###

(a)Study ####

(1)In general The Comptroller General of the United States (in this section referred to as the “Comptroller General”) shall conduct a study on the requirements applicable to, and challenges of, hospice programs with regard to the management and disposal of controlled substances in the home of an individual. ####

(2)Contents In conducting the study under paragraph (1), the Comptroller General shall include— #####

(A)an overview of any challenges encountered by selected hospice programs regarding the disposal of controlled substances, such as opioids, in a home setting, including any key changes in policies, procedures, or best practices for the disposal of controlled substances over time; and #####

(B)a description of Federal requirements, including requirements under the Medicare program, for hospice programs regarding the disposal of controlled substances in a home setting, and oversight of compliance with those requirements. ###

(b)Report Not later than 18 months after the date of enactment of this Act, the Comptroller General shall submit to Congress a report containing the results of the study conducted under subsection (a), together with recommendations, if any, for such legislation and administrative action as the Comptroller General determines appropriate. ## CHAPTER 4 SPECIAL REGISTRATION FOR TELEMEDICINE CLARIFICATION